HALO Breast Pap Test
– HALO is noninvasive, objective and repeatable, plus it’s quick – just 5 minutes
– HALO has been proven a safe and effective method to collect nipple aspirate fluid for analysis
– Routine assessment with HALO will enable breast health monitoring and the ability to react to cellular changes early
The HALO® Breast Pap Test is FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre-malignant versus malignant cells.
Incorporating Halo into routine practice will enable physicians and patients to monitor cellular changes within breast ducts earlier, before they develop into larger, potentially cancerous lesions.
The HALO System is a simple, reliable method for NAF collection. NAF analysis is an objective assessment of a patient’s breast health and can detect early warning signs of ductal cellular changes. Regular assessment and tracking of cellular changes in the milk ducts, where most breast cancer begins, enables clinicians and patients to take control of breast health.